Allergic Fungal Sinusitis (AFS) is a common type of fungal infection which affects the sinuses. The infection is caused by fungi found in the environment and leads to an allergic reaction in patients, resulting in very thick mucus, fungal debris collecting in the sinuses and blocked sinuses. Patients often have symptoms such as allergies, nasal polyps and sometimes asthma. If left untreated, AFS can develop into a chronic condition, Fungal Chronic Rhinosinusitis (FCRS), affecting the senses of smell and sight.
A new study by researchers in France provides useful information that can help clinicians to diagnose AFS before patients develop FCRS that requires surgery.
The researchers studied a group of 75 patients for 12 months, who had all been recommended for surgery to treat their FCRS. They looked for a variety of criteria that would have allowed the diagnosis of AFS before surgery, these included:
- Blood tests to look for immune system markers such as immunoglobulin E and white blood cells
- CAT scans
- MRI scans
- Microscopic examination of the debris and mucus found in the sinuses
The study found that Aspergillus was the most commonly isolated type of fungus in the study (65%) and results suggest that AFS can be reliably diagnosed by measuring total and anti-Aspergillus IgE levels and undertaking sinus MRI and CT scans.
Currently, definitive diagnosis of AFS is only confirmed after surgery has taken place by studying the material recovered from the sinuses. Describing new diagnostic indicators will help to support the decision to undergo complete surgical removal of fungal debris and mucus plugs from patients with CRS.
Share this post
Latest News posts
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
Aspergillosis Weekly Support Meeting
February 15, 2021
An aspergillosis diagnostic journey
February 5, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
COVID Vaccine for Aspergillosis Patients
December 11, 2020
COVID Precautions for the extremely vulnerable: Winter 2020
November 23, 2020
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video